COLL
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc historical holders
total: 1
Third Avenue Management Collegium Pharmaceutical Inc transactions over time
- Total transactions:
- 6
- New positions:
- 1
- Added:
- 4
- Reduced:
- 1
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
Third Avenue Management has been an institutional investor in Collegium Pharmaceutical Inc (COLL) since 2023 Q4. According to 2026 Q1 report, Third Avenue Management holds 155,143 shares with a market value of roughly $5.13M representing 0.83% of their equity portfolio. The fund/company first acquired COLL in 2023 Q4, initially purchasing 83,120 shares. Since the initial investment, Third Avenue Management has made 5 more transactions in this position.
Does Third Avenue Management still hold COLL?
Yes, Third Avenue Management continues to hold Collegium Pharmaceutical Inc (COLL). According to their 2026 Q1 report, they maintain a position of 155,143 shares valued at approximately $5.13M, representing 0.83% of their equity portfolio.
When did Third Avenue Management first invest in COLL?
Third Avenue Management first invested in Collegium Pharmaceutical Inc (COLL) in 2023 Q4 at the reported quarter-end price of $30.78 per share, acquiring 83,120 shares in their initial purchase.
What is Third Avenue Management's average cost basis for COLL?
Based on historical transaction data, Third Avenue Management's estimated cost basis for Collegium Pharmaceutical Inc (COLL) is approximately $32.08 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $32.08
- Weighted AVG sell price:
- $33.07
COLL transactions history by Third Avenue Management
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.83%
|
155,143
|
$33.07
|
$5,130,579
|
-23.73% (-48,258)
|
-0.29%
|
|
2024 Q4
|
1.13%
|
203,401
|
$28.65
|
$5,827,439
|
+11.36% (+20,750)
|
+0.12%
|
|
2024 Q3
|
1.15%
|
182,651
|
$38.64
|
$7,057,635
|
+0.20% (+370)
|
+0%
|
|
2024 Q2
|
1.01%
|
182,281
|
$32.20
|
$5,869,448
|
+68.59% (+74,161)
|
+0.41%
|
|
2024 Q1
|
0.67%
|
108,120
|
$38.82
|
$4,197,218
|
+30.08% (+25,000)
|
+0.15%
|
|
2023 Q4
|
0.42%
|
83,120
|
$30.78
|
$2,558,434
|
new
|
+0.42%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.